Topoisomerase II cleavable complex formation within DNA loop domains

Biochemical Pharmacology

Volumn 60, Issue 1, 2000, Pages 101-109

  Lambert, Joseph M ^a   Fernandes, Daniel J ^a  

^a MEDICAL UNIVERSITY OF SOUTH CAROLINA   (United States)

Author keywords

DNA replication; Nuclear matrix; Teniposide; Topoisomerase II; VM 26

Indexed keywords

DNA TOPOISOMERASE (ATP HYDROLYSING); TENIPOSIDE;

APOPTOSIS; ARTICLE; BINDING SITE; CELL LINE; CELL NUCLEUS MATRIX; CELL VIABILITY; COMPLEX FORMATION; CONTROLLED STUDY; CYTOCHEMISTRY; CYTOTOXICITY; DNA BINDING; DNA DAMAGE; DNA STRUCTURE; HUMAN; HUMAN CELL; IN VITRO STUDY; PRIORITY JOURNAL;

ANTINEOPLASTIC AGENTS; APOPTOSIS; BINDING SITES; DNA; DNA REPLICATION; DNA TOPOISOMERASES, TYPE II; ENZYME INHIBITORS; HUMANS; NUCLEAR MATRIX; NUCLEIC ACID CONFORMATION; TENIPOSIDE; TIME FACTORS; TRITIUM; TUMOR CELLS, CULTURED;

EID: 0034052314     PISSN: 00062952     EISSN: None     Source Type: Journal    
DOI: 10.1016/S0006-2952(00)00309-9     Document Type: Article

References (39)

1. Liu L.F., Rowe T.C., Yang L., Tewey K.M., Chen G.L. Cleavage of DNA by mammalian DNA topoisomerase II. J Biol Chem. 258:1983;15365-15370.
2. Osheroff N. Effect of antineoplastic agents on the DNA cleavage/religation reaction of eukaryotic topoisomerase II Inhibition of DNA religation by etoposide . Biochemistry. 28:1989;6157-6160.
3. Hsiang Y.H., Hertzberg R., Hecht S., Liu L.F. Camptothecin induces protein-linked DNA breaks via mammalian DNA topoisomerase I. J Biol Chem. 260:1985;14873-14878.
4. Muscarella D.E., Rachlinski M.K., Sotiriadis J., Bloom S.E. Contribution of gene-specific lesions, DNA-replication-associated damage, and subsequent transcriptional inhibition in topoisomerase inhibitor-mediated apoptosis in lymphoma cells. Exp Cell Res. 238:1998;155-167.
5. Nelson W.G., Liu L.F., Coffey D.S. Newly replicated DNA is associated with DNA topoisomerase II in cultured rat prostatic adenocarcinoma cells. Nature. 322:1986;187-189.
6. Woynarowski J.M., Sigmund R.D., Beerman T.A. Topoisomerase-II-mediated lesions in nascent DNA Comparison of the effects of epipodophyllotoxin derivatives, VM-26 and VP-16, and 9-anilinoacridine derivatives, m-AMSA and o-AMSA . Biochim Biophys Acta. 950:1988;21-29.
7. Catapano C.V., Carbone G.M., Pisani F., Qiu J., Fernandes D.J. Arrest of replication fork progression at sites of topoisomerase II-mediated DNA cleavage in human leukemia CEM cells incubated with VM-26. Biochemistry. 36:1997;5739-5748.
8. Qiu J., Catapano C.V., Fernandes D.J. Formation of topoisomerase IIα complexes with nascent DNA is related to VM-26-induced cytotoxicity. Biochemistry. 35:1996;16354-16360.
9. Drake F.H., Hofmann G.A., Bartus H.F., Mattern M.R., Crooke S.T., Mirabelli C.K. Biochemical and pharmacological properties of p170 and p180 forms of topoisomerase II. Biochemistry. 28:1989;8154-8160.
10. Woessner R.D., Mattern M.R., Mirabelli C.K., Johnson R.K., Drake F.H. Proliferation- and cell cycle-dependent differences in expression of the 170 kilodalton and 180 kilodalton forms of topoisomerase II in NIH-3T3 cells. Cell Growth Differ. 2:1991;209-214.
11. Pienta KJ and Coffey DS, A structural analysis of the role of the nuclear matrix and DNA loops in the organization of the nucleus and chromosome. J Cell Sci Suppl 1: 123-135, 1984.
12. Nelson W.G., Pienta K.J., Barrack E.R., Coffey D.S. The role of the nuclear matrix in the organization and function of DNA. Annu Rev Biophys Biophys Chem. 15:1986;457-475.
13. Vogelstein B., Pardoll D.M., Coffey D.S. Supercoiled loops and eucaryotic DNA replicaton. Cell. 22:1980;79-85.
14. Cook P.R., Brazell I.A. Conformational constraints in nuclear DNA. J Cell Sci. 22:1976;287-302.
15. Gasser S.M., Laemmli U.K. The organisation of chromatin loops Characterization of a scaffold attachment site . EMBO J. 5:1986;511-518.
16. Berezney R. Organization and functions of the nuclear matrix. Hnilica L. Chromosomal Nonhistone Proteins. 1984;119-180 CRC Press, Boca Raton.
17. Fernandes D.J., Smith-Nanni C., Paff M.T., Neff T.A. Effects of antileukemia agents on nuclear matrix-bound DNA replication in CCRF-CEM leukemia cells. Cancer Res. 48:1988;1850-1855.
18. Pardoll D.M., Vogelstein B., Coffey D.S. A fixed site of DNA replication in eucaryotic cells. Cell. 19:1980;527-536.
19. Danks M.K., Qiu J., Catapano C.V., Schmidt C.A., Beck W.T., Fernandes D.J. Subcellular distribution of the α and β topoisomerase II-DNA complexes stabilized by VM-26. Biochem Pharmacol. 48:1994;1785-1795.
20. Wu H.Y., Shyy S.H., Wang J.C., Liu L.F. Transcription generates positively and negatively supercoiled domains in the template. Cell. 53:1988;433-440.
21. Fernandes D.J., Danks M.K., Beck W.T. Decreased nuclear matrix DNA topoisomerase II in human leukemia cells resistant to VM-26 and m-AMSA. Biochemistry. 29:1990;4235-4241.
22. Valkov N.I., Gump J.L., Sullivan D.M. Quantitative immunofluorescence and immunoelectron microscopy of the topoisomerase IIα associated with nuclear matrices from wild-type and drug-resistant Chinese hamster ovary cell lines. J Cell Biochem. 67:1997;112-130.
23. Ling Y.H., Zou Y., Priebe W., Perez-Soler R. Partial circumvention of multi-drug resistance by annamycin is associated with comparable inhibition of DNA synthesis in the nuclear matrix of sensitive and resistant cells. Int J Cancer. 61:1995;402-408.
24. Koopman G., Reutelingsperger C.P., Kuijten G.A., Keehnen R.M., Pals S.T., van Oers M.H. Annexin V for flow cytometric detection of phosphatidylserine expression on B cells undergoing apoptosis. Blood. 84:1994;1415-1420.
25. van Engeland M., Ramaekers F.C., Schutte B., Reutelingsperger C.P. A novel assay to measure loss of plasma membrane asymmetry during apoptosis of adherent cells in culture. Cytometry. 24:1996;131-139.
26. Payne C.M., Bernstein C., Bernstein H. Apoptosis overview emphasizing the role of oxidative stress, DNA damage and signal-transduction pathways. Leuk Lymphoma. 19:1995;43-93.
27. Strife R.J., Jardine I., Colvin M. Analysis of the anticancer drugs VP 16-213 and VM 26 and their metabolites by high-performance liquid chromatography. J Chromatogr. 182:1980;211-220.
28. Rowe T.C., Chen G.L., Hsiang Y.H., Liu L.F. DNA damage by antitumor acridines mediated by mammalian DNA topoisomerase II. Cancer Res. 46:1986;2021-2026.
29. Woynarowski J.M., McHugh M.M., Gawron L.S., Beerman T.A. Effects of bizelesin (U-77779), a bifunctional alkylating minor groove agent, on genomic and simian virus 40 DNA. Biochemistry. 34:1995;13042-13050.
30. 2/M arrest Higher order DNA fragmentation as an indicator of mechanism . Br J Cancer. 77:1998;40-50.
31. Li T.-K., Yu C., Xiao H., Mao Y., Wang H., Liu L. Activation of toposiomerase II-mediated excision of chromosomal DNA loops by oxidative and PH stresses. Proc Am Assoc Cancer Res. 40:1999;682.
32. Martelli A.M., Bareggi R., Bortul R., Grill V., Narducci P., Zweyer M. The nuclear matrix and apoptosis. Histochem Cell Biol. 108:1997;1-10.
33. DePamphilis M.L. Specific labeling of newly replicated DNA. Methods Enzymol. 262:1995;628-669.
34. Borgnetto M.E., Zunino F., Tinelli S., Käs E., Capranico G. Drug-specific sites of topoisomerase II DNA cleavage in Drosophila chromatin Heterogeneous localization and reversibility . Cancer Res. 56:1996;1855-1862.
35. Udvardy A., Schedl P. The dynamics of chromatin condensation Redistribution of topoisomerase II in the 87A7 heat shock locus during induction and recovery . Mol Cell Biol. 13:1993;7522-7530.
36. Kaufmann W.K., Boyer J.C., Estabrooks L.L., Wilson S.J. Inhibition of replicon initiation in human cells following stabilization of topoisomerase-DNA cleavable complexes. Mol Cell Biol. 11:1991;3711-3718.
37. Haim N., Roman J., Nemec J., Sinha B.K. Peroxidative free radical formation and O-demethylation of etoposide (VP-16) and teniposide (VM-26). Biochem Biophys Res Commun. 135:1986;215-220.
38. Haim N., Nemec J., Roman J., Sinha B.K. Peroxidase-catalyzed metabolism of etoposide (VP-16-213) and covalent binding of reactive intermediates to cellular macromolecules. Cancer Res. 47:1987;5835-5840.
39. Kalyanaraman B., Nemec J., Sinha B.K. Characterization of free radicals produced during oxidation of etoposide (VP-16) and its catechol and quinone derivatives. An ESR study. Biochemistry. 28:1989;4839-4846.